RAPH
Raphael Pharmaceutical Inc

2
Loading...
Loading...
Raphael Pharmaceutical, Inc. is a clinical-stage biotechnology company. It is focused on providing a novel cannabinoid-based research platform for the treatment of inflammatory diseases. The firm’s product candidate, HPC1, is a cannabinoid formulation developed for the treatment of rheumatoid arthritis. The company was founded in May 2007 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Raphael Pharmaceutical Inc?
What is the 52-week high for Raphael Pharmaceutical Inc?
What is the 52-week low for Raphael Pharmaceutical Inc?
What is Raphael Pharmaceutical Inc stock price today?
What was Raphael Pharmaceutical Inc stock price yesterday?
What is the PE ratio of Raphael Pharmaceutical Inc?
What is the Price-to-Book ratio of Raphael Pharmaceutical Inc?
What is the 50-day moving average of Raphael Pharmaceutical Inc?

Latest RAPH News

View
No RAPH news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.